These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8737128

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
    Aubier M, Lode H, Gialdroni-Grassi G, Huchon G, Hosie J, Legakis N, Regamey C, Segev S, Vester R, Wijnands WJ, Tolstuchow N.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():73-82. PubMed ID: 8737127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B, Dutchman DA, Pettit R, Maroli A.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
    Henry D, Ellison W, Sullivan J, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2262-6. PubMed ID: 9736546
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
    Ramirez J, Unowsky J, Talbot GH, Zhang H, Townsend L.
    Clin Ther; 1999 Jan; 21(1):103-17. PubMed ID: 10090428
    [Abstract] [Full Text] [Related]

  • 10. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
    Allegra L, Konietzko N, Leophonte P, Hosie J, Pauwels R, Guyen JN, Petitpretz P.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
    Lipsky BA, Dorr MB, Magner DJ, Talbot GH.
    Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432
    [Abstract] [Full Text] [Related]

  • 13. Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group.
    Ortqvist A, Valtonen M, Cars O, Wahl M, Saikku P, Jean C.
    Chest; 1996 Dec; 110(6):1499-506. PubMed ID: 8989068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
    Trémolières F, de Kock F, Pluck N, Daniel R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):447-53. PubMed ID: 9758291
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC, Nenad RC, Iravani A, Tice AD, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [Abstract] [Full Text] [Related]

  • 17. Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
    Grassi GG, Brumpt I.
    Drugs; 1995 Jun; 49 Suppl 2():406-8. PubMed ID: 8549379
    [No Abstract] [Full Text] [Related]

  • 18. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG, Owens RC, Quintiliani R, Nightingale CH.
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract] [Full Text] [Related]

  • 19. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr 25; 39(999):41-3. PubMed ID: 9137295
    [No Abstract] [Full Text] [Related]

  • 20. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
    Lode H, Magyar P, Muir JF, Loos U, Kleutgens K, International Gatifloxacin Study Group.
    Clin Microbiol Infect; 2004 Jun 25; 10(6):512-20. PubMed ID: 15191378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.